3SBio, Inc. (TRSBF)
3SBio Market Cap : 6.087B for March 6, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Sinovac Biotech Ltd. | 464.94M |
| CASI Pharmaceuticals, Inc. | 4.315M |
| Zai Lab Ltd. | 2.190B |
| WuXi Biologics (Cayman), Inc. | 18.57B |
| Viva Biotech Holdings | 724.45M |
Market Cap Related Metrics
| PS Ratio | 5.077 |
| PEG Ratio | 0.9515 |
| Price to Book Value | 40.50 |
| Price to Free Cash Flow | 16.81 |
| Price | 2.58 |
| Earnings Yield | 5.12% |
| PEGY Ratio | 0.897 |
| Operating PE Ratio | 19.31 |
| Normalized PE Ratio | 19.46 |